Suma Krishnan, President, R&D, 10% Owner at Krystal Biotech, Inc. (KRYS), sold 4 shares at $80.01 ($320) on 2022-11-23, disclosed to the SEC on 2022-11-28.
Scheduled sale ($320) by President, R&D, 10% Owner under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| KRYS | SELL | 2026-03-06 | $13.2M | — | Filing → |
| KRYS | SELL | 2025-12-05 | $20.9M | — | Filing → |
| KRYS | SELL | 2025-07-16 | $10.1M | — | Filing → |